Concourse Financial Group Securities, Inc. Bone Biologics Corp Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.21 - $0.39 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$0.19 - $32.7 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$0.16 - $35.1 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$0.14 - $0.41 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$0.23 - $0.77 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$0.64 - $1.26 $0 - $0
0 New
0 $0

About Bone Biologics Corp

BBLG Quotes by TradingView
  • Ticker BBLG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,128,400
  • Market Cap $13M
  • Description
  • Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for sp...
More about BBLG
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email